Company filings profile · CIK 0001882782
Odyssey Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Odyssey Therapeutics, Inc. (ODTX): 52 filings in the last 90 days vs 2 in the prior 90 (filing-velocity rising ↑ · 26×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — Odyssey Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 17, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 11, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
Watch Odyssey Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 17, 2026 | 10-Q | 10-Q | ↗ |
| Jun 17, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 5, 2026 | SCHEDULE 13G | ↗ | |
| May 18, 2026 | SCHEDULE 13G | ↗ | |
| May 18, 2026 | SCHEDULE 13D | ↗ | |
| May 18, 2026 | SCHEDULE 13D | ↗ | |
| May 15, 2026 | SCHEDULE 13D | ↗ | |
| May 15, 2026 | SCHEDULE 13D | ↗ | |
| May 13, 2026 | 4 | FORM 4 | ↗ |
| May 12, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| May 12, 2026 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| May 11, 2026 | S-8 | S-8 | ↗ |
| May 8, 2026 | 424B4 | 424B4 | ↗ |
| May 7, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |
| May 7, 2026 | 3 | 3 | ↗ |